$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Immunosuppression in pancreas transplantation: progress, problems and perspective

Transplant immunology, v.6 no.2, 1998년, pp.69 - 77  

Stratta, Robert J (Address for correspondence: RJ Stratta, University of Tennessee-Memphis, Department of Surgery, 956 Court Avenue, Suite A202, Memphis, Tennessee 38163-2116, USA.)

Abstract AI-Helper 아이콘AI-Helper

AbstractThrough 1997, over 10 000 pancreas transplants have been performed world-wide, with 88% being simultaneous kidney-pancreas transplants (SKPTs). Current 1-year patient survival exceeds 90% and pancreas graft survival (complete insulin independence) exceeds 80% for SKPT, 70% for sequential pan...

참고문헌 (67)

  1. Annu Rev Med Stratta 46 281 1995 10.1146/annurev.med.46.1.281 Pancreas transplantation for diabetes mellitus 

  2. Gruessner 47 1994 Pancreas transplantation in the United States (US) and non-US as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) 

  3. Surgery Sollinger 102 674 1987 Pancreas transplantation with pancreaticocystostomy and quadruple immunosuppression 

  4. Transplant Proc Wadstrom 27 1317 1995 Triple versus quadruple induction immunosuppression in pancreas transplantation 

  5. Transplant Proc Brayman 26 2525 1994 Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era? 

  6. The International Congress on Immunosuppression, Orlando, Florida Cantarovich 11 1997 Randomized comparison of triple therapy versus anti-thymocyte globulin induction following combined pancreas-renal transplantation 

  7. Transplant Proc Stratta 26 546 1994 OKT3-induction in 100 consecutive pancreas transplants 

  8. Transplant Proc Stratta 28 917 1996 A prospective randomized trial of OKT3 versus ATGAM-induction therapy in pancreas transplant recipients 

  9. Transplant Proc Knechtle 23 1581 1991 OKT3 versus ALG induction therapy in combined pancreas-kidney transplantation 

  10. Transplant Proc Ilner 22 1586 1990 Quadruple-drug induction therapy in combined renal and pancreatic transplantation: OKT3 versus ATG 

  11. Transplant Proc Sutherland 26 2752 1994 Pancreas transplant outcome with or without biological anti-T cell therapy for induction immunosuppression with use of cyclosporine 

  12. Clin Transplant Sutherland 5 549 1991 Immunosuppression for clinical pancreas transplantation 

  13. Transplant Proc Rosenberg 29 35S 1997 10.1016/S0041-1345(97)80010-3 Pancreas transplantation with ATG versus OKT3 

  14. Transplant Proc Gruessner 26 437 1994 Assessment of donor and recipient risk factors on pancreas transplant outcome 

  15. Transplant Proc Brayman 24 91 1992 Factors leading to improved outcome following pancreas transplantation - the influence of immunosuppression and HLA matching 

  16. Transplant Proc Shapiro 27 3087 1995 Successful pancreas-renal transplantation without anti-T cell antibody induction 

  17. Acta Diabetol Corry 34 125 1997 Tacrolimus without anti-lymphocyte induction therapy prevents pancreas loss from rejection in 100 consecutive patients 

  18. Transplantation Van Der Pijl 62 456 1996 10.1097/00007890-199608270-00006 Pharmacokinetics of the conventional and microemulsion formulations of cyclosporine in pancreas-kidney transplant recipients with gastroparesis 

  19. Transplant Proc Storck 27 3094 1995 Cyclosporine resorption in diabetic patients after simultaneous pancreas and kidney transplantation 

  20. Clin Transplant Lang 3 1 1989 Cyclosporine pharmacokinetics in diabetic patients after kidney and pancreas transplantation 

  21. Transplant Proc Serafinowicz 28 3140 1996 Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus treated with Sandimmune and Sandimmune Neoral 

  22. Transplant Proc Rigotti 29 2924 1997 10.1016/S0041-1345(97)00731-8 Neoral versus Sandimmune in kidney-pancreas transplantation 

  23. Transplantation Chapman 61 1699 1996 10.1097/00007890-199606270-00006 Reversal of cyclosporine malabsorption in diabetic recipients of simultaneous pancreas and kidney transplants using a microemulsion formulation 

  24. Transplant Proc Dawidson 27 134 1995 Cyclosporine blood levels predict the likelihood of rejection and toxicity after simultaneous pancreas-kidney transplantation 

  25. Transplantation Gruessner 61 261 1996 10.1097/00007890-199601270-00018 Multicentre analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation 

  26. Clin Transplant Gruessner 11 299 1997 Tacrolimus in pancreas transplantation: a multicentre analysis 

  27. Transplantation Hariharan 61 1161 1996 10.1097/00007890-199604270-00007 Rescue therapy with tacrolimus after combined kidney-pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity 

  28. Transplant Proc Stratta 28 991 1996 FK506 induction and rescue therapy in pancreas transplant recipients 

  29. Transplant Proc Teraoka 27 1335 1995 Effect of rescue therapy using FK506 on relapsing rejection after combined pancreas and kidney transplantation 

  30. Transplantation Shaffer 59 1063 1995 10.1097/00007890-199504150-00028 Normal pancreas allograft function following simultaneous pancreas kidney transplantation after rescue therapy with tacrolimus (FK506) 

  31. Transplant Int Becker 10 51 1997 10.1111/j.1432-2277.1997.tb00536.x Rescue therapy with tacrolimus in simultaneous pancreas-kidney transplantation 

  32. Transplant Proc Demirbas 29 2903 1997 10.1016/S0041-1345(97)00723-9 FK506 in simultaneous pancreas/kidney transplantation: The University of Miami experience 

  33. Transplant Proc Alloway 28 995 1996 Conversion from cyclosporine to tacrolimus in kidney, kidney-pancreas, and pancreas alone transplant recipients: the Memphis experience 

  34. Transplant Proc Burke 27 3123 1995 The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression 

  35. Acta Diabetol Peddi 34 162 1997 Use of tacrolimus-based immunosuppression eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation 

  36. Ann Surg Bartlett 224 440 1996 10.1097/00000658-199610000-00003 Equivalent success of simultaneous pancreas-kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immuno-suppression with percutaneous biopsy 

  37. Transplantation Gruessner 64 1572 1997 10.1097/00007890-199712150-00011 Solitary pancreas transplantation for nonuremic patients with labile insulin-dependent diabetes mellitus 

  38. Transplantation Sollinger 60 225 1995 10.1097/00007890-199508000-00003 Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients 

  39. Lancet 345 1321 1995 10.1016/S0140-6736(95)92534-1 Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection 

  40. American Society of Transplant Physicians, 15th Annual Scientific Meeting, Dallas, TX Stratta 26291996 Mycophenolate mofetil (MMF) induction and conversion therapy in pancreas transplant recipients 

  41. Acta Diabetol Elkhammas 34 161 1997 Combined kidney/pancreas transplantation: comparison of mycophenolate mofetil versus azathioprine 

  42. Transplantation Odorico 65 240(645A) 1998 10.1097/00007890-199805131-00642 A study comparing mycophenlate mofetil to azathioprine in simultaneous pancreas-kidney transplantation 

  43. Acta Diabetol Gritsch 34 162 1997 Comparison of azathioprine and mycophenolate mofetil in pancreas transplantation 

  44. American Society of Transplant Physicians, 16th Annual Scientific Meeting. Chicago, IL Marcos 10141997 Mycophenolate mofetil is associated with decreased incidence of severity of acute cellular rejection following simultaneous kidney/pancreas transplant 

  45. Transplant Proc Stratta 29 654 1997 10.1016/S0041-1345(96)00383-1 Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: a multicentre report 

  46. Acta Diabetol Gruessner 34 125 1997 Mycophenolate mofetil and tacrolimus in pancreas transplantation 

  47. Transplantation Stegall 64 1695 1997 10.1097/00007890-199712270-00011 Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine 

  48. Transplantation Reddy 65 251(691A) 1998 10.1097/00007890-199805131-00688 Simultaneous kidney-pancreas transplantation without anti-lymphocyte induction 

  49. Acta Diabetol Bruce 34 161 1997 Effects of tacrolimus, mycophenolate mofetil, and microemulsified cyclosporine on rejection incidence in synchronous pancreas/kidney transplantation 

  50. Transplant Proc Burke 36 1544 1998 10.1016/S0041-1345(98)00350-9 The use of tacrolimus and mycophenolate mofetil for pancreas/kidney transplantation with or without OKT3 induction 

  51. Acta Diabetol Busing 34 126 1997 Mycophenolate mofetil/tacrolimus/single shot ATG versus azathioprine/cyclosporine in pancreas-kidney transplantation: Results of a prospective randomized single-center study 

  52. Acta Diabetol Kaufman 34 120 1997 Results with tacrolimus/mycophenolate mofetil primary maintenance immunosuppression in simultaneous pancreas/kidney transplantation 

  53. Acta Diabetol Kahl 34 162 1997 First results with a quadruple therapy regimen including tacrolimus and mycophenolate mofetil in patients after combined pancreas and kidney transplantation 

  54. American Society of Transplant Surgeons, 23rd Annual Scientific Meeting, Chicago, IL Lee 14161997 FK506 and mycophenolate mofetil: the superior strategy for simultaneous pancreas-kidney patients 

  55. Transplant Immunol Zucker 5 225 1997 10.1016/S0966-3274(97)80042-1 Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings 

  56. J Invest Med Larsen 42 622 1994 Consequences of pancreas transplantation 

  57. Curr Probl Surg Stratta 33 709 1996 10.1016/S0011-3840(96)80006-2 Pancreas transplantation: a managed cure approach to diabetes 

  58. Transpl Proc Cantarovich 23 2224 1991 Maintenance immunosuppression without corticosteroids following combined pancreas and kidney transplantation 

  59. Transplantation Hricik 54 868 1992 10.1097/00007890-199211000-00019 The effects of steroid withdrawal on the lipoprotein in profiles of cyclosporine-treated kidney and kidney-pancreas transplant recipients 

  60. Acta Diabetol Elmer 34 118 1997 Tacrolimus versus cyclosporin A: effects on glucose utilization in portally drained pancreas allografts 

  61. N Engl J Med Tyden 335 860 1996 10.1056/NEJM199609193351205 Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts 

  62. Trans Assoc Am Physicians Sutherland 97 80 1984 Twin-to-twin pancreas transplantation: reversal and re-enactment of the pathogenesis of Type I diabetes 

  63. Transplantation Larsen 56 1533 1993 Evidence that fasting hyperproinsulinemia after combined pancreas-kidney transplantation diminishes over time 

  64. Diabetes Diem 39 534 1990 10.2337/diabetes.39.5.534 Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients 

  65. Diabetes Care Milde 18 93 1995 10.2337/diacare.18.1.93 Pancreatic transplantation: impact on the quality of life of diabetic renal transplant recipients 

  66. Transplant Proc Hathaway 27 3065 1995 Identification of quality-of-life outcomes distinguishing diabetic kidney-alone and pancreas-kidney recipients 

  67. Diabetologica Zehrer 34 S145 1991 10.1007/BF00587643 Quality-of-life of pancreas transplant recipients 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로